GSK-2879552 is a lysine-specific histone demethylase-1A (LSD1 or lysine demethylase 1A, KDM1A) inhibitor and was investigated for its activity against small cell lung cancer (SCLC), acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS), however clinical trials were terminated [143,144]. This evidence concerns the gene KDM1A and small cell lung carcinoma.